[go: up one dir, main page]

Ferraz et al., 2009 - Google Patents

2-Benzoylpyridine-N (4)-tolyl thiosemicarbazones and their palladium (II) complexes: cytotoxicity against leukemia cells

Ferraz et al., 2009

View HTML
Document ID
8563669838456322822
Author
Ferraz K
Ferandes L
Carrilho D
Pinto M
de Fátima Leite M
Souza–Fagundes E
Speziali N
Mendes I
Beraldo H
Publication year
Publication venue
Bioorganic & medicinal chemistry

External Links

Snippet

The palladium (II) complexes [Pd (2Bz4oT) Cl],[Pd (2Bz4mT) Cl], and [Pd (2Bz4pT) Cl] were prepared with N (4)-ortho-(H2Bz4oT) N (4)-meta-(H2Bz4mT) and N (4)-para-(H2Bz4pT) tolyl- thiosemicarbazones derived from 2-benzoylpyridine. The free thiosemicarbazones proved to …
Continue reading at www.sciencedirect.com (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic System
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals

Similar Documents

Publication Publication Date Title
Ferraz et al. 2-Benzoylpyridine-N (4)-tolyl thiosemicarbazones and their palladium (II) complexes: cytotoxicity against leukemia cells
Reis et al. Antimony (III) complexes with 2-benzoylpyridine-derived thiosemicarbazones: cytotoxicity against human leukemia cell lines
Mendes et al. Gallium (III) complexes of 2-pyridineformamide thiosemicarbazones: cytotoxic activity against malignant glioblastoma
Mohapatra et al. DFT, anticancer, antioxidant and molecular docking investigations of some ternary Ni (II) complexes with 2-[(E)-[4-(dimethylamino) phenyl] methyleneamino] phenol
Despaigne et al. 2-Acetylpyridine-and 2-benzoylpyridine-derived hydrazones and their gallium (III) complexes are highly cytotoxic to glioma cells
Ude et al. A novel dual-functioning ruthenium (II)–arene complex of an anti-microbial ciprofloxacin derivative—Anti-proliferative and anti-microbial activity
Zhang et al. Synthesis, molecular modeling and biological evaluation of chalcone thiosemicarbazide derivatives as novel anticancer agents
Ari et al. Synthesis, structural characterization and cell death-inducing effect of novel palladium (II) and platinum (II) saccharinate complexes with 2-(hydroxymethyl) pyridine and 2-(2-hydroxyethyl) pyridine on cancer cells in vitro
Gou et al. α− N− heterocyclic thiosemicarbazone Fe (III) complex: Characterization of its antitumor activity and identification of anticancer mechanism
Haque et al. Non-symmetrically substituted N-heterocyclic carbene–Ag (I) complexes of benzimidazol-2-ylidenes: Synthesis, crystal structures, anticancer activity and transmetallation studies
Parrilha et al. Metal complexes with 2-acetylpyridine-N (4)-orthochlorophenylthiosemicarbazone: Cytotoxicity and effect on the enzymatic activity of thioredoxin reductase and glutathione reductase
Eshkourfu et al. Synthesis, characterization, cytotoxic activity and DNA binding properties of the novel dinuclear cobalt (III) complex with the condensation product of 2-acetylpyridine and malonic acid dihydrazide
Bakale et al. Mixed ligand complex via zinc (II)-mediated in situ oxidative heterocyclization of hydrochloride salt of 2-chlorobenzaldehyde hydralazine hydrazone as potential of antihypertensive agent
Gao et al. Synthesis, characterization, interaction with DNA and cytotoxicity in vitro of the complexes [M (dmphen)(CO3)]· H2O [M= Pt (II), Pd (II)]
Lessa et al. 2-Acetylpyridine thiosemicarbazones: cytotoxic activity in nanomolar doses against malignant gliomas
Ferraz et al. Investigation on the pharmacological profile of 2, 6-diacetylpyridine bis (benzoylhydrazone) derivatives and their antimony (III) and bismuth (III) complexes
Kovala-Demertzi et al. Synthesis, crystal structure, spectral properties and cytotoxic activity of platinum (II) complexes of 2-acetyl pyridine and pyridine-2-carbaldehyde N (4)-ethyl-thiosemicarbazones
Mitra et al. Anticancer Activity of Hydrogen‐Bond‐Stabilized Half‐Sandwich RuII Complexes with Heterocycles
Arslan et al. The iron (III) and nickel (II) complexes with tetradentate thiosemicarbazones. Synthesis, experimental, theoretical characterization, and antiviral effect against SARS-CoV-2
Khan et al. Rhodium (III) complexes with isoquinoline derivatives as potential anticancer agents: in vitro and in vivo activity studies
Mendes et al. Organotin (IV) complexes of 2-pyridineformamide-derived thiosemicarbazones: Antimicrobial and cytotoxic effects
Tai et al. Cadmium (II) and indium (III) complexes derived from 2-benzoylpyridine N (4)-cyclohexylthiosemicarbazone: Synthesis, crystal structures, spectroscopic characterization and cytotoxicity
Parrilha et al. 2-Acetylpyridine-and 2-benzoylpyridine-derived thiosemicarbazones and their antimony (III) complexes exhibit high anti-trypanosomal activity
Porta et al. An in vivo active 1, 2, 5-oxadiazole Pt (II) complex: A promising anticancer agent endowed with STAT3 inhibitory properties
Ferraz et al. N (4)-Tolyl-2-acetylpyridine thiosemicarbazones and their platinum (II, IV) and gold (III) complexes: cytotoxicity against human glioma cells and studies on the mode of action